Home > Healthcare > Medical Devices > Diagnostic Devices > Liver Disease Diagnostics Market
Liver Disease Diagnostics Market size was valued at around USD 39.5 billion in 2023 and is estimated to grow at 7.3% CAGR from 2024 to 2032. The increasing prevalence of liver diseases, growing awareness regarding liver related complications and the importance of early diagnosis, rising geriatric population, and continuous advancements in diagnostic technologies.
Moreover, the high prevalence of liver diseases, such as non-alcoholic fatty liver disease (NAFLD), viral hepatitis, and liver cirrhosis, is a major concern for people with sedentary lifestyles and weak immunity. Obesity, viral infections, alcohol and drug consumption, among other factors are contributing to the rising burden of liver disorders in the world. For instance, as per the article published by Clinical and Molecular Hepatology, NAFLD affects around 32% of individuals worldwide, with a greater incidence among males (40%) than females (26%).
Liver disease diagnostics refer to the various methods and procedures employed to identify, assess, and monitor diseases or conditions affecting the liver. The liver is a vital organ responsible for numerous functions, including detoxification, metabolism, and the production of proteins necessary for blood clotting. Liver diseases encompass a wide range of conditions, such as hepatitis, cirrhosis, fatty liver disease, and liver cancer.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Liver Disease Diagnostics Market Size in 2023: | USD 39.5 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 7.3% |
2032 Value Projection: | USD 74.6 Billion |
Historical Data for: | 2018 - 2023 |
No. of Pages: | 110 |
Tables, Charts & Figures: | 214 |
Segments covered: | Disease Type, Technique, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|